Literature DB >> 29268422

Design of interventional studies in thoracic surgery.

Zachary W Fitch1, John Z Deng1, Chi-Fu Jeffrey Yang1, Thomas A D'Amico1.   

Abstract

Interventional studies differ from observational studies in that one or more specific interventions are evaluated. Randomized controlled trials remain the gold standard for interventional studies and can take different forms. In surgical studies, the three types of randomized controlled trials most commonly encountered are: (I) trials that compare two different medical treatments for patients undergoing surgery; (II) trials that evaluate two different surgical techniques and (III) studies that compare surgery vs. non-operative management. When an intervention is to be evaluated but a randomized controlled trial is not feasible, alternative interventional study designs may be considered.

Entities:  

Keywords:  Interventional study; randomized controlled trial; thoracic surgery

Year:  2017        PMID: 29268422      PMCID: PMC5723789          DOI: 10.21037/jtd.2017.09.04

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  7 in total

Review 1.  Randomised trials in surgery: problems and possible solutions.

Authors:  Peter McCulloch; Irving Taylor; Mitsuru Sasako; Bryony Lovett; Damian Griffin
Journal:  BMJ       Date:  2002-06-15

2.  Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.

Authors:  Miklos Pless; Roger Stupp; Hans-Beat Ris; Rolf A Stahel; Walter Weder; Sandra Thierstein; Marie-Aline Gerard; Alexandros Xyrafas; Martin Früh; Richard Cathomas; Alfred Zippelius; Arnaud Roth; Milorad Bijelovic; Adrian Ochsenbein; Urs R Meier; Christoph Mamot; Daniel Rauch; Oliver Gautschi; Daniel C Betticher; René-Olivier Mirimanoff; Solange Peters
Journal:  Lancet       Date:  2015-08-11       Impact factor: 79.321

3.  No surgical innovation without evaluation: the IDEAL recommendations.

Authors:  Peter McCulloch; Douglas G Altman; W Bruce Campbell; David R Flum; Paul Glasziou; John C Marshall; Jon Nicholl; Jeffrey K Aronson; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; Liane S Feldman; David R Flum; Guy J Maddern; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Steven M Strasberg; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Patrick L Ergina; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Jonathan Meakins; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Study designs in thoracic surgery research.

Authors:  Andrea Viti; Alberto Terzi; Luca Bertolaccini
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

6.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

7.  National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical Training.

Authors:  Karl Y Bilimoria; Jeanette W Chung; Larry V Hedges; Allison R Dahlke; Remi Love; Mark E Cohen; David B Hoyt; Anthony D Yang; John L Tarpley; John D Mellinger; David M Mahvi; Rachel R Kelz; Clifford Y Ko; David D Odell; Jonah J Stulberg; Frank R Lewis
Journal:  N Engl J Med       Date:  2016-02-02       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.